Yahoo Web Search

Search results

    • Small Business - Cordele Dispatch | Cordele Dispatch

      Cordele Dispatch· 5 days ago

      Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by deregulated transcription, today announced the ...

    • Small Business - Shelby County Reporter | Shelby County Reporter

      The Shelby County Reporter· 5 days ago

      Multiple refractory PD1 failure patients experienced prolonged progression free survival (10 months ongoing); confirmed responses observed in patients receiving evalstotug High doses of evalstotug as either a monotherapy or in combination with